BOUT

Fund Description
The Innovator IBD Breakout Opportunities ETF seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investors Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the securitys recent "resistance level", with consideration for various market conditions.
Fund Profile
Fund Name Innovator IBD Breakout Opportunities ETF
Fund Exchange Ticker BOUT
Fund Sponsor Innovator Management
Fund ISIN US45782C7636
Net Expense Ratio 0.84 %
Fund Inception Date 13 September 2018
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Factor & Thematic
Asset Class Equities (Stocks)
Index Linked Passive
Index Name IBD Breakout Stocks Index
Index Provider IBD
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 31 July 2020
Asset Under Management 6.05 Million (USD)
1 Month Total Return 7.85 %
Year To Date Return 14.84 %
1 Year Total Return 13.30 %
3 Year Annualized Total Return
NAV 24.2028
Share Outstanding 250,000
Top 10 Holdings (31 July 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
GFL ENVIRONMENTAL INC GFL EQUI 0.0594000000
KROGER CO KR EQUI 0.0566000000
ASGN INC ASGN EQUI 0.0566000000
QORVO INC QRVO EQUI 0.0555000000
ABBVIE INC ABBV EQUI 0.0552000000
PAYPAL HOLDINGS INC PYPL EQUI 0.0551000000
MURPHY USA INC MUSA EQUI 0.0550000000
AUTONATION INC AN EQUI 0.0531000000
MSCI INC MSCI EQUI 0.0472000000
WHEATON PRECIOUS METALS CORP WPM EQUI 0.0461000000